View of A REVIEW ON THE ROLE OF PPARÎ³ AGONISTS AND HYBRIDS IN TYPE 2 DIABETES AND CARDIOMYOPATHY.

Return to Article Details A REVIEW ON THE ROLE OF PPARÎ³ AGONISTS AND HYBRIDS IN TYPE 2 DIABETES AND CARDIOMYOPATHY. Download Download PDF